DIA
INO icon

Denver Investment Advisors’s Inovio Pharmaceuticals INO Stock Holding History

Denver Investment Advisors’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-843
Closed -$68K – 495
2015
Q4 		$68K Sell
843
-95
-10% -$7.56K ﹤0.01% 493
2015
Q3 		$65K Sell
938
-33
-3% -$2.88K ﹤0.01% 522
2015
Q2 		$95K Sell
971
-265
-21% -$28.3K ﹤0.01% 547
2015
Q1 		$121K Sell
1,236
-26
-2% -$2.52K ﹤0.01% 611
2014
Q4 		$139K Buy
+1,262
New +$154K ﹤0.01% 595

Other funds holding INO

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SIP
Stoneridge Investment Partners Radnor, Pennsylvania $138M AUM 7.66% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Denver Investment Advisors's INO Position: Q1 2016 in Review

Denver Investment Advisors sold out of Inovio Pharmaceuticals (INO) in Q1 2016, closing a stake of 843 shares — an estimated $68K sold.

Denver Investment Advisors first reported a position in INO in Q4 2014 and held it in 5 quarters. The position peaked at $139K in Q4 2014. 115 funds tracked by Wall St. Rank hold INO as of Q1 2016.

  • Denver Investment Advisors reported no remaining Inovio Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Denver Investment Advisors sold 843 Inovio Pharmaceuticals shares in Q1 2016, an estimated $68K.
  • Denver Investment Advisors first reported a position in Inovio Pharmaceuticals in Q4 2014 and held it in 5 quarters.
  • Denver Investment Advisors's Inovio Pharmaceuticals position peaked at $139K in Q4 2014.
  • 115 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2016.

Based on Denver Investment Advisors's 13F filing for Q1 2016, filed 12 May 2016.